Avantel Board Approves MoA Alteration & Subsidiary Merger

Avantel Ltd's Board of Directors, at a meeting on September 18, 2026, approved two significant proposals. Firstly, they sanctioned the alteration of the company's Memorandum of Association (MoA) to include additional objects under the Main Objects Clause. These new objects indicate a strategic expansion into areas such as medical devices, healthcare services, and space/satellite technologies. This alteration is contingent on shareholder approval via Postal Ballot. Secondly, the Board considered and approved the merger of Imeds Global Private Limited, a wholly-owned subsidiary, into Avantel Limited, in accordance with the Companies Act, 2013. A notice for the postal ballot regarding the MoA alteration was also approved.